Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab.
Ann Neurol
; 91(6): 796-800, 2022 06.
Article
in En
| MEDLINE
| ID: mdl-35243687
Full text:
1
Database:
MEDLINE
Main subject:
COVID-19
/
Multiple Sclerosis
Limits:
Humans
Language:
En
Year:
2022
Type:
Article